Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Facial Dermatitis Herpetiformis with Allergy Diseases Improved by Administration of Mahaengeuigam-tang

마행의감탕(麻杏薏甘湯)으로 호전된 알레르기 질환을 동반한 안면부 포진상 피부염 치험 1례

  • Lee, Ju-Hyun (Department of Ophthalmology, Otolaryngology & Dermatology, College of Korean Medicine, Wonkwang University) ;
  • Park, Ji-Won (Department of Korean Medicine Acupuncture and Moxibustion, College of Korean Medicine, Wonkwang University) ;
  • Jo, Eun-Heui (Department of Korean Medicine Acupuncture and Moxibustion, College of Korean Medicine, Wonkwang University) ;
  • Park, Min-Cheol (Department of Ophthalmology, Otolaryngology & Dermatology, College of Korean Medicine, Wonkwang University)
  • 이주현 (원광대학교 한의과대학 한방안이비인후피부과학교실) ;
  • 박지원 (원광대학교 한의과대학 침구의학교실) ;
  • 조은희 (원광대학교 한의과대학 침구의학교실) ;
  • 박민철 (원광대학교 한의과대학 한방안이비인후피부과학교실)
  • Received : 2022.03.21
  • Accepted : 2022.07.12
  • Published : 2022.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

This study aims to report a case of facial dermatitis herpetiformis with allergy diseases improved by administration of Mahaengeuigam-tang (Maxingyigan-tang). Multiple blisters appeared on the patient's face, Erythema, papules, and scales were also observed on the neck, back, and knee areas of the patient. The patient has had cough, sputum, and dyspnea symptoms since she was 5-6 months old. After diagnosing the patient's condition as dermatitis herpetiformis, atopic dermatitis, and bronchial asthma through history taking and symptom observation, Mahaengeuigam-tang (Maxingyigan-tang) was prescribed for about 30 days. As a result of evaluation through our own criteria, dermatitis herpetiformis symptoms improved from 18 to 2 points. Atopic dermatitis and asthma symptoms also decreased from 12 to 0 and 20 to 3 points, respectively. Since this study has proven the efficacy of Mahaengeuigam-tang (Maxingyigan-tang) for dermatitis herpetiformis patient, this prescription may be fully utilized as the treatment for other inflammatory skin diseases.

Keywords

Acknowledgement

이 논문은 2022년도 원광대학교의 교내 연구비 지원에 의해서 수행됨.

References

  1. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195(6):747-57. https://doi.org/10.1084/jem.20011299
  2. Katz SI, Strober W. The pathogenesis of dermatitis herpetiformis. J Invest Dermatol. 1978;70(2):63-75. https://doi.org/10.1111/1523-1747.ep12541202
  3. Park SB, Youn FJ, Ko WS. A case report of IgA dermatitis herpetiformis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2001;14(2):35-8.
  4. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136(3):315-8. https://doi.org/10.1111/j.1365-2133.1997.tb14935.x
  5. Waserman S, Watson W. Food allergy. Allergy Asthma Clin Immunol. 2011;S7.
  6. Bantz SKB, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;5:1-6.
  7. Caproni M, Antiga E, Melani L, Fabbri P. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009;23(6):633-8. https://doi.org/10.1111/j.1468-3083.2009.03188.x
  8. Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015;8:257-65. https://doi.org/10.2147/CCID.S69127
  9. Roh EM, Moon YH. Anti-inflammatory, analgesic and antipyretic actions of Mahaengeuigam-Tang. Korean Journal of Pharmacognosy. 2001;32(3):242-7.
  10. Kim SG, Kim MJ, Go SJ, Park JW. A case study of plantar wart improved with Mahaengeuigam-tang. J Korean Med Internal Korean Medicine. 2014:280-4.
  11. Kim BH. The protective effects of Mahaengeuigam-Tang against monosodium jodoacetate induced osteoarthritis in rats. Herb Formula Sci. 2018;26(4):283-94.
  12. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44-7. https://doi.org/10.2340/00015555924447
  13. Fabbri P, Calabro AS, Hashimoto T, Fasano A, Caproni M. Novel advances in dermatitis herpetiformis. J Immunol Res. 2012. https://doi.org/10.1155/2012/450109.
  14. Marks R, Whittle MW, Beard RJ, Robertson WB, Gold SC. Small-bowel abnormalities in dermatitis herpetiformis. Br Med J. 1968;1(5591):552-5. https://doi.org/10.1136/bmj.1.5591.552
  15. Gawkrodger DJ, Blackwell JN, Gilmour HM, Rifkind EA, Heading RC, Barnetson RS. Dermatitis herpetiformis: Diagnosis, diet and demography. Gut. 1984;25:151-7. https://doi.org/10.1136/gut.25.2.151
  16. Mansikka E, Hervonen K, Kaukinen K, Collin P, Huhtala H, Reunala T, et al. Prognosis of dermatitis herpetiformis patients with and without villous atrophy at diagnosis. Nutrients. 2018;10(5):641. https://doi.org/10.3390/nu10050641
  17. Kwak DY. Interpretation of the Geum-Gwe-Yo-Ryak. 1st ed. Seoul:Sungbosa;2002. 62-64.
  18. Liang S, Meng X, Wang Z, Liu J, Kuang H, Wnag Q. Polysaccharide from Ephedra sinica Stapf inhibits inflammation expression by regulating Factor-β1/Smad2 signaling. Int J Biol Macromol. 2018;106:947-54. https://doi.org/10.1016/j.ijbiomac.2017.08.096
  19. Yun HJ, Lee YJ, Kang MS, Baek JH. Inhibitory effect of Coicis Semen Extract(CSE) on pro-inflammatory mediatory. J Pediatr Korean Med. 2009;23(1):159-71.